This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiriboga, C. A.
Right arrow Articles by Hauser, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiriboga, C. A.
Right arrow Articles by Hauser, W. A.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 103 No. 1 January 1999, pp. 79-85

Dose-Response Effect of Fetal Cocaine Exposure on Newborn Neurologic Function

Received Feb 16, 1998; accepted May 18, 1998.

Claudia A. Chiriboga*, parallel , John C. M. BrustDagger , parallel , David Bateman§, parallel , and W. Allen HauserDagger , , #

From the * Division of Pediatric Neurology, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York; the Dagger  Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York; the § Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York; the parallel  Harlem Hospital Center, New York, New York; the  Sergievsky Center, Columbia University, New York, New York; and the # School of Public Health, Columbia University, New York, New York.

Background.  Studies of fetal cocaine exposure and newborn neurologic function have obtained conflicting results. Although some studies identify abnormalities, others find no differences between cocaine-exposed and cocaine-unexposed infants. To determine the effects of prenatal cocaine exposure on intrauterine growth and neurologic function in infants, we prospectively evaluated 253 infants shortly after birth.

Methods.  Women who delivered a live singleton >36 weeks by dates were eligible for enrollment. Maternal exclusionary criteria were known parenteral drug use, alcoholism, and acquired immunodeficiency syndrome; infant exclusionary criteria were Apgar scores <= 4 at 5 minutes, obvious congenital malformations, seizures, or strokes. A total of 98% of infants were evaluated between 1 to 7 days of age. Newborns were assessed with the Neurological Examination for Children (NEC) by a pediatric neurologist (C.A.C.) who was blinded to exposure status. Gestational age was determined by Ballard's examination. Cocaine exposure was determined for the last trimester by radioimmunoassay of maternal hair (RIAH). Exposure values ranged from 2 to 4457 ng/10 mg hair. Infants were excluded if a maternal hair sample was missing (N = 13). The sample comprises 240 woman and infant pairs---104 cocaine-exposed and 136 cocaine-unexposed.

Results.  Compared with unexposed controls, cocaine-exposed infants exhibited higher rates of intrauterine growth retardation (24% vs 8%), small head circumference ([HC] <10th% percentile) (20% vs 5%) and neurologic abnormalities: global hypertonia (32% vs 11%), coarse tremor (40% vs 15%), and extensor leg posture (20% vs 4%). We found increasing odds (odds ratio) of growth and neurologic impairment with increasing level of cocaine exposure in stratified analyses. The odds ratio associated with three levels of cocaine exposure (no exposure, low exposure = RIAH 2-66 ng/mg; and high exposure = RIAH 81-4457 ng/mg) respectively are: 1.0, 3.3, and 6.1 for small head size (chi 2 for trend); 1.0, 3.3, and 4.3 for global hypertonia (chi 2 for trend); 1.0, 3.4, and 7.4 for extensor leg posturing (chi 2 for trend); and 1.0, 3.8, and 3.8 for coarse tremor (chi 2 for trend). Significant associations between cocaine exposure and neurologic signs were found in logistic regression equations that controlled for 20 or more variables.

Conclusion.  We conclude that adverse neonatal effects associated with fetal cocaine exposure follow a dose-response relationship: newborns with higher levels of prenatal cocaine exposure show higher rates of impairments in fetal head growth and abnormalities of muscle tone, movements, and posture. Significant relationships between cocaine exposure and these outcomes remain in controlled analyses.  Key words:  neurologic, in utero, cocaine exposure, neonates, hypertonia, central nervous system, movement disorder.




This article has been cited by other articles:


Home page
 PediatricsHome page
M. A. Tan-Laxa, C. Sison-Switala, W. Rintelman, and E. M. Ostrea Jr
Abnormal Auditory Brainstem Response Among Infants With Prenatal Cocaine Exposure
Pediatrics, February 1, 2004; 113(2): 357 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Remedial and Special EducationHome page
S. M.R. Watson and C. E. Westby
Prenatal Drug Exposure: Implications for Personnel Preparation
Remedial and Special Education, August 1, 2003; 24(4): 204 - 214.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
B Bar-Oz, J Klein, T Karaskov, and G Koren
Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F98 - F100.
[Abstract] [Full Text] [PDF]

Home page
 Communication Disorders QuarterlyHome page
S. M. R. Watson and C. E. Westby
Strategies for Addressing the Executive Function Impairments of Students Prenatally Exposed to Alcohol and Other Drugs
Communication Disorders Quarterly, January 1, 2003; 24(4): 194 - 204.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
H S Bada, C R Bauer, S Shankaran, B Lester, L L Wright, A Das, K Poole, V L Smeriglio, L P Finnegan, and P L Maza
Central and autonomic system signs with in utero drug exposure
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2002; 87(2): F106 - 112.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. A. Frank, M. Augustyn, W. G. Knight, T. Pell, and B. Zuckerman
Growth, Development, and Behavior in Early Childhood Following Prenatal Cocaine Exposure: A Systematic Review
JAMA, March 28, 2001; 285(12): 1613 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. A. Bateman and C. A. Chiriboga
Dose-Response Effect of Cocaine on Newborn Head Circumference
Pediatrics, September 1, 2000; 106(3): 33e - 33.
[Abstract] [Full Text]

Home page
 PediatricsHome page
D. A. Dempsey, B. L. Hajnal, J. C. Partridge, S. N. Jacobson, W. Good, R. T. Jones, and D. M. Ferriero
Tone Abnormalities Are Associated With Maternal Cigarette Smoking During Pregnancy in In Utero Cocaine-Exposed Infants
Pediatrics, July 1, 2000; 106(1): 79 - 85.
[Abstract] [Full Text]